Versant Venture Capital III, L.P., 10% Owner at Immune Design Corp. (IMDZ), bought 765,173 shares at $12.00 ($2.8M) on 2014-07-29, disclosed to the SEC on 2014-07-31.
Open-market purchase of $2.8M IMDZ by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 531,840 | $0 | 0.0% |
| 2 | $12.00 | 233,333 | $2.8M | 100.0% |
| Total | $3.66 avg | 765,173 | $2.8M | 100% |
| Filing → |